Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | D816F |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | KIT D816F lies within the tyrosine kinase domain 2 of the Kit protein (PMID: 17555444). D816F results in constitutive phosphorylation of Kit and activation of Stat3, Mapk, and Akt signaling in cultured cells (PMID: 9990072, PMID: 16397263), and also confers resistance to imatinib in culture (PMID: 16397263). |
Associated Drug Resistance | Y |
Category Variants Paths |
KIT mutant KIT act mut KIT D816F KIT mutant KIT exon17 KIT D816X KIT D816F |
Transcript | NM_000222.3 |
gDNA | chr4:g.54733154_54733155delGAinsTT |
cDNA | c.2446_2447delGAinsTT |
Protein | p.D816F |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001385290.1 | chr4:g.54733154_54733155delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
XM_017008179 | chr4:g.54733166_54733167delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_001385292.1 | chr4:g.54733166_54733167delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_001093772 | chr4:g.54733166_54733167delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54733154_54733155delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
XM_005265741 | chr4:g.54733154_54733155delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54733166_54733167delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54733154_54733155delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_001093772.1 | chr4:g.54733166_54733167delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
XM_017008179.1 | chr4:g.54733166_54733167delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54733154_54733155delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
XM_005265741.1 | chr4:g.54733154_54733155delGAinsTT | c.2446_2447delGAinsTT | p.D816F | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT D816F | Advanced Solid Tumor | resistant | Imatinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT D816F were resistant to Gleevec (imatinib mesylate) in culture (PMID: 16397263). | 16397263 |